BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Shares Repurchased (2020 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Shares Repurchased of $42.5 million for Q3 2026, down 66.7% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Shares Repurchased (2020 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, BridgeBio Pharma's Shares Repurchased came in at $252.5 million, up 423.0% year-over-year; for FY2025, it came in at $48.28 million.

  • Shares Repurchased has a five-year compound annual growth rate of -8.4% (FY2020 to FY2025).
  • By year, Shares Repurchased came in at $200 million in FY2021 (+166.7%).
  • The Q3 2026 figure ranks as the lowest quarterly Shares Repurchased since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 370.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn 42.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 42.50 Mn
Jun 30, 2026 127.50 Mn
Mar 31, 2026 82.50 Mn
Mar 31, 2025 48.28 Mn
Dec 31, 2021 1.54 Mn
Sep 30, 2021 143.15 Mn
Jun 30, 2021 5.31 Mn
Mar 31, 2021 50.00 Mn
Mar 31, 2020 75.00 Mn
API Access

BridgeBio Pharma Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=BBIO&period=max&api_key=YOUR_API_KEY